MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2017 International Congress

June 4-8, 2017. Vancouver, BC.

View by Title View Sessions
View by Date
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • The battery longevity of implantable pulse generators (IPG) in Parkinson’s disease (PD) is affected by IPG model, number of previous IPG replacements and stimulation energy delivered.

    S. Israeli-Korn, T. Fay-Karmon, S. Tessler, G. Yahalom, S. Benizri, H. Strauss, Z. Zibly, R. Spiegelmann, S. Hassin (Ramat Gan, Israel)

  • The brain plasticity for controlling reach-to-grasp functions of Parkinson’s disease

    J. Tretriluxana, S. Tretriluxana, J. Thanakamchokchai, A. Nanbancha, A. Pisarnpong (Nakhon Pathom, Thailand)

  • The Cats & Dogs Test: a web-based platform to detect early visual processing deficits in Parkinson’s disease

    R. Weil, B. Bahrami, D. Schwarzkopf, I. Pavisic, K. Pappa, R. Schade, H. Morris (London, United Kingdom)

  • The clinical and neuroimaging analysis in hemifacial spasm with associated cranial neuropathy: retrospective case series study

    Y.-Y. Chang, Y.-F. Chen, Y.-F. Chen, M.-Y. Lan, J.-S. Liu (Kaohsiung, Taiwan)

  • The clinical phenotype of progressive supranuclear gaze palsy with predominant cerebellar ataxia (PSP-C): a case series

    Z. Xu, T. Lim, W.L. Au, L. Tan (Singapore, Singapore)

  • The clinical profile associated to Amyloid-beta 42 and Tau cerebrospinal fluid levels in non-demented PD patients

    I. Liepelt-Scarfone, F. Klumpp, W. Maetzler, S. Nussbaum, M. Timmers, G. Salvadore, K. Brockmann, T. Gasser, S. Becker, J. Streffer, D. Berg (Tübingen, Germany)

  • The clinically-available anti-depressant mirtazapine alleviates both psychosis and dyskinesia in the MPTP-lesioned marmoset

    I. Frouni, S. Nuara, N. Veyres, C. Kwan, M.-J. Harraka, V. Nafade, L. Sid-Otmane, J. Gourdon, H. Adjia, P. Huot (Montreal, QC, Canada)

  • The combination of clinical scales and walking measures to predict falls in Parkinson’s disease: Does the length of the prospective follow-up period matter?

    R. Vitório, R. Moraes, A. Baptista, E. Lirani-Silva, L. Simieli, D. Orcioli-Silva, F. Barbieri, L. Gobbi (Rio Claro, Brazil)

  • The combination of the MIBG myocardial scintigraphy and DATSPECT contributes to the diagnosis of PD and other related disorders.

    S. Tada, H. Ohtsubo, Y. Yamanishi, N. Miyaue, R. Ando, H. Yabe, N. Nishikawa, M. Nagai, M. Miyagawa, M. Nomoto (Ehime, Japan)

  • The comparison of urine microvesicle reflecting gut microbiome between Parkinson’s disease and healthy control

    J. Park, S. Park, W. Jang, J.S. Kim, J. Yoon, E. Oh (Busan, Republic of Korea)

  • « Previous Page
  • 1
  • …
  • 134
  • 135
  • 136
  • 137
  • 138
  • …
  • 155
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley